Navigation Links
Abbott's Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
Date:6/7/2008

TriLipix in Combination with CRESTOR (rosuvastatin calcium) Demonstrates

Similar Lipid Effects in Patients with Diabetes and Overall Study

Population

SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- New data from a sub-group analysis of patients with mixed dyslipidemia and type 2 diabetes that were enrolled in a Phase III study showed that the use of Abbott's investigational TriLipix(TM) (ABT-335) in combination with AstraZeneca's CRESTOR(R) (rosuvastatin calcium), demonstrated similar improvements in LDL "bad" cholesterol, HDL "good" cholesterol and triglycerides compared to the overall study population. These data were presented today at the American Diabetes Association's (ADA) 68th Annual Scientific Sessions in San Francisco.

Abbott evaluated the efficacy and safety of TriLipix in combination with rosuvastatin in a Phase III study of more than 1,400 patients with mixed dyslipidemia. This study, presented at the National Lipid Association annual meeting on May 31, 2008, met its primary endpoints. TriLipix in combination with rosuvastatin significantly improved HDL and triglycerides compared to rosuvastatin alone, and significantly improved LDL compared to TriLipix alone.

Of the patients enrolled in this study, a sub-group of 276 patients were identified as having type 2 diabetes. Data from this sub-group demonstrated that the comprehensive effect of TriLipix in combination with rosuvastatin was similar to that seen in the overall study population. Compared to corresponding monotherapies, patients receiving TriLipix in combination with rosuvastatin had significant decreases in triglycerides and LDL, in addition to clinically meaningful improvements in HDL.

Dyslipidemia affects millions of Americans living with diabetes. These patients often have mixed dyslipidemia, a complex combination of lipid problems commonly characterized by high triglycerides, low HDL and moderately high LDL.

"T
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
2. Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add-on Therapy Studies
3. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
4. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
5. Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkins Lymphoma
6. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
7. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
8. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
9. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
10. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
11. Kosans Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...WYORK,Nov.25/PRNewswire/--Reportlinker.comannounce...ogue: ,, IntranasalDrugDelivery-USMarketTrends...7/Intranasal-Drug-Delivery---US-Market-Trends--Ana...tiswitnessinganexpansionoftherapeuticapplicationsf...othedeliveryofsystemictherapeuticdrugs.Thefutureof...
(Date:11/25/2009)...AMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCal...HIN),aleadinginnovatorandprovideroflessinvasive,mi...izingthetreatmentofadvancedheartfailure,todayannou...tthe21stAnnualPiperJaffrayHealthCareConferenceat8:...eingheldattheNewYorkPalaceHotel,December1-2. ,,...
(Date:11/24/2009)...THESDA,Md.,Nov.24/PRNewswire-Asia/--ChindexInterna...ependentAmericanproviderofWestern,healthcareproduc...nouncedthattheCompanywillattendthe21stAnnualPiperJ...ember1-2,2009,atthe,NewYorkPalaceHotel. , Man...uesday,December1,2009,andholdone-on-onemeetingsth...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 1Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 2Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 3Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 4Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 1Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 2The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 1The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 2
...UBLIN, Calif., Dec. 8 SuperGen Inc. (Nasdaq: S...iscovery and development of novel cancer therapies...or, SGI-1776, is effective both in vitro and in vi...ukemia (ALL) (Abstract #1922) . This research wa...ican Society of Hematology. , , In a poster p...
...RINCETON, N.J., Dec. 8 Medarex, Inc. (Nasdaq:, M...tudy for MDX-1401, a,second-generation non-fucosyl...r for activated lymphocytes that is present on the...l as other CD30-expressing cancers. MDX-1401,demon...in cell lines when,compared to MDX-060. The improv...
Other Medicine Technology:SuperGen's PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia 2SuperGen's PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia 3Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma 2Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma 3
(Date:11/27/2009)...ings has announced that it has become a national s...gest nonprofit organizations dedicated to arthriti... Delray Beach, FL (Vocus) November..., a company specializing in the marketing and reta...as announced today that is has become a national s...
(Date:11/27/2009)... bilingual coloring books designed for children ag...nity to educate - inform parents and children alik...inosuars to ABC,S and a host of other topics. , ...ember 27, 2009 -- Today’s children have enou...any hour of the day, but one of the oldest and sim...
(Date:11/26/2009)...mericans living with diabetes will nearly double, ...on in 2034. Over the same period, spending on diab...to $336 billion, even with no increase in the prev...sity of Chicago report in the December issue of D...es covered by Medicare will rise from 8.2 million ...
(Date:11/26/2009)... of the Live Life Again Center, a practice offerin...wing number of physicians who are taking advantag...th individuals who are interested in surgical weig... is utilizing Facebook to share before-and-after p...community. , Dallas, TX (...
(Date:11/25/2009)...e/--TheBartleHallConventionCenterwilltemporarilybe...KansasCityhoststhelatestinaseriesofmassivefreeclin...asthepotentialtobethebiggestoneyet,becauseitwillex...insteadofoveraweekend,"SheriWood,executivedirector...tionalAssociationofFreeClinics(NAFC). ,, Atprev...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...Live, a not for,profit corporation, received a set...ts fight against the FDA on behalf of terminal can... will immediately file an,appeal in the 6th Circui...ongress needs,to wake up and hold hearings immedia...
...ology to Install Milestone Unit at ...v. 26 ZONARE Medical Systems, a developer of,prem... Society of North,America (RSNA) Annual Congress, ...ter. The Center is one of the most,respected cance...
...ics,Incorporated (NYSE: DGX ), the nation,s leadi... services, announced that it is scheduled to speak...ference at the Merrill,Lynch Headquarters in New Y...the company will reiterate its 2007 guidance for,r...
...tive herbicide tolerant systems and ...IM, Germany, Nov. 26 Bayer CropScience AG, Mertec...t they have entered into a,longterm collaboration ...et with the opportunity to expand to other,soybean...
...re not the best for them, study says , , M...rd of prostate cancer patients may receive treatme...y are already having with urinary, bowel or sexual...r favors a particular type of treatment, according...
...,Think About Their Drink, SOUTH BEND, Ind., Nov....winners selected in the Think About Your ... nationwide., WHAT: The Adams family en...ion campaign, the nation,s milk processor...
Other Medicine News:Health News:CareToLive Reports: The FDA Fiddles While 30,000 Men Burn 2Health News:CareToLive Reports: The FDA Fiddles While 30,000 Men Burn 3Health News:ZONARE Surpasses 1000th Worldwide z.one Ultrasound System Shipment 2Health News:ZONARE Surpasses 1000th Worldwide z.one Ultrasound System Shipment 3Health News:Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference 2Health News:Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products 2Health News:Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products 3Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 2Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 3Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 4Health News:South Bend Area Family Wins Nationwide got milk? Contest 2Health News:South Bend Area Family Wins Nationwide got milk? Contest 3
Dual Channel Airways
Berman Airways
Soft Clear Guedel with Color Code Individually Bagged Oropharyngeal Airways
Color Coded Berman Oropharyngeal Airways - 50/Bag
Medicine Products: